{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:53:16Z","timestamp":1783486396590,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T00:00:00Z","timestamp":1336521600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.6061\/clinics\/2012(sup01)19","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T17:56:33Z","timestamp":1335290193000},"page":"113-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S1","title":["Multiple endocrine neoplasia type 2: achievements and current challenges"],"prefix":"10.1016","volume":"67","author":[{"given":"Andreas","family":"Machens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.6061\/clinics\/2012(Sup01)19_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0002-9343(61)90234-0","article-title":"The association of pheochromocytoma with carcinoma of the thyroid gland","volume":"31","author":"Sipple","year":"1961","journal-title":"Am J Med"},{"key":"10.6061\/clinics\/2012(Sup01)19_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2","volume":"276","author":"Eng","year":"1996","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)19_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2796.2009.02113.x","article-title":"Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities","volume":"266","author":"Machens","year":"2009","journal-title":"J Intern Med"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)19_bib4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.surg.2008.08.028","article-title":"Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: an exploratory analysis","volume":"144","author":"Brauckhoff","year":"2008","journal-title":"Surgery"},{"issue":"18","key":"10.6061\/clinics\/2012(Sup01)19_bib5","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM197811022991804","article-title":"Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis","volume":"299","author":"Graze","year":"1978","journal-title":"N Engl J Med"},{"issue":"8","key":"10.6061\/clinics\/2012(Sup01)19_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJM198802253180804","article-title":"The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience","volume":"318","author":"Gagel","year":"1988","journal-title":"N Engl J Med"},{"issue":"8","key":"10.6061\/clinics\/2012(Sup01)19_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s004230000169","article-title":"Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation","volume":"385","author":"Machens","year":"2000","journal-title":"Langenbecks Arch Surg"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)19_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum Mol Genet"},{"issue":"6428","key":"10.6061\/clinics\/2012(Sup01)19_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"issue":"6461","key":"10.6061\/clinics\/2012(Sup01)19_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/367375a0","article-title":"A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma","volume":"367","author":"Hofstra","year":"1994","journal-title":"Nature"},{"issue":"12","key":"10.6061\/clinics\/2012(Sup01)19_bib11","first-page":"2415","article-title":"RET mutations in exons 13 and 14 of FMTC patients","volume":"10","author":"Bolino","year":"1995","journal-title":"Oncogene"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)19_bib12","first-page":"509","article-title":"A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC","volume":"10","author":"Eng","year":"1995","journal-title":"Oncogene"},{"issue":"12","key":"10.6061\/clinics\/2012(Sup01)19_bib13","first-page":"4176","article-title":"A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma","volume":"82","author":"Hofstra","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)19_bib14","first-page":"770","article-title":"A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A","volume":"83","author":"Berndt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"10.6061\/clinics\/2012(Sup01)19_bib15","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","article-title":"European Multiple Endocrine Neoplasia (EUROMEN) Study Group. Early malignant progression of hereditary medullary thyroid cancer","volume":"349","author":"Machens","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)19_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SLA.0b013e3181ae333f","article-title":"Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels","volume":"250","author":"Machens","year":"2009","journal-title":"Ann Surg"},{"issue":"11","key":"10.6061\/clinics\/2012(Sup01)19_bib17","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1210\/jc.2003-030997","article-title":"A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma","volume":"88","author":"Da Silva","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)19_bib18","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/jc.2005-0064","article-title":"Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2","volume":"90","author":"Machens","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)19_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2265.2007.03153.x","article-title":"Familial prevalence and age of RET germline mutations: implications for screening","volume":"69","author":"Machens","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)19_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1530\/EJE-08-0476","article-title":"Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene","volume":"159","author":"Peppa","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.6061\/clinics\/2012(Sup01)19_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1530\/EJE-08-0854","article-title":"Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B","volume":"160","author":"Zenaty","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)19_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-10-0333","article-title":"Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes","volume":"163","author":"Romei","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)19_bib23","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1210\/jc.2010-0375","article-title":"The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A","volume":"95","author":"Schulte","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)19_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/humu.21385","article-title":"International RET Exon 10 Consortium. Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10","volume":"32","author":"Frank-Raue","year":"2011","journal-title":"Hum Mutat"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)19_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/thy.2010.0328","article-title":"Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation","volume":"21","author":"Jasim","year":"2011","journal-title":"Thyroid"},{"issue":"5","key":"10.6061\/clinics\/2012(Sup01)19_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/thy.2010.0336","article-title":"Primary hyperparathyroidism as the first clinical manifestation of multiple endocrine neoplasia type 2a in a 5-year-old child","volume":"21","author":"Magalh\u00e3es","year":"2011","journal-title":"Thyroid"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)19_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2010.01453.x","article-title":"RET codon 804 mutations in multiple endocrine neoplasia 2: genotype\u2013phenotype correlations and implications in clinical management","volume":"79","author":"Mukherjee","year":"2011","journal-title":"Clin Genet"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)19_bib28","doi-asserted-by":"crossref","first-page":"E509","DOI":"10.1210\/jc.2010-1234","article-title":"Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines","volume":"96","author":"Rohmer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.6061\/clinics\/2012(Sup01)19_bib29","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1909::AID-CNCR21>3.0.CO;2-A","article-title":"Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis","volume":"88","author":"Machens","year":"2000","journal-title":"Cancer"},{"issue":"5","key":"10.6061\/clinics\/2012(Sup01)19_bib30","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1210\/jc.2002-021713","article-title":"Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer","volume":"88","author":"Scollo","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)19_bib31","first-page":"612","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"issue":"10","key":"10.6061\/clinics\/2012(Sup01)19_bib32","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1373\/clinchem.2003.026963","article-title":"Reference intervals for serum calcitonin in men, women, and children","volume":"50","author":"Basuyau","year":"2004","journal-title":"Clin Chem"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)19_bib33","first-page":"17","article-title":"Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay","volume":"66","author":"Verga","year":"2006","journal-title":"Horm Res"},{"key":"10.6061\/clinics\/2012(Sup01)19_bib34","article-title":"for the French Group of Endocrine Tumors (GTE). Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma","author":"Bihan","year":"2011","journal-title":"Head Neck"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)19_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2265.2008.03197.x","article-title":"The Y606C RET mutation causes a receptor gain of function","volume":"69","author":"Ercolino","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)19_bib36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/thy.2007.0365","article-title":"A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma","volume":"18","author":"Fazioli","year":"2008","journal-title":"Thyroid"},{"issue":"4","key":"10.6061\/clinics\/2012(Sup01)19_bib37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/ERC-10-0306","article-title":"Functional characterization of the MTC-associated germ line RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism","volume":"18","author":"Borrello","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)19_bib38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2265.2011.04158.x","article-title":"Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation","volume":"75","author":"Machens","year":"2011","journal-title":"Clin Endocrinol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322202405X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322202405X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-67-s1\/cln-67-s1-113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:15:10Z","timestamp":1761722110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S180759322202405X"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322012001300019&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3328837\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":38,"alternative-id":["S180759322202405X"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2012(sup01)19","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple endocrine neoplasia type 2: achievements and current challenges","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2012(Sup01)19","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}